{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Richmond+Park&max-answer.dateOfAnswer=2014-10-27", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberConstituency=Richmond+Park&max-answer.dateOfAnswer=2014-10-27", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Richmond+Park&_metadata=all&max-answer.dateOfAnswer=2014-10-27", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&tablingMemberConstituency=Richmond+Park&max-answer.dateOfAnswer=2014-10-27", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Richmond+Park&max-answer.dateOfAnswer=2014-10-27", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Richmond+Park&max-answer.dateOfAnswer=2014-10-27", "items" : [{"_about" : "http://data.parliament.uk/resources/93136", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/93136/answer", "answerText" : {"_value" : "
None of the munitions supplied to UK Forces for use over Iraq contains depleted uranium; there are no UK forces operating in Syria. There are no plans to issue depleted uranium weapons to UK forces operating over Iraq.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1444", "label" : {"_value" : "Biography information for Mr Mark Francois"} } , "answeringMemberConstituency" : {"_value" : "Rayleigh and Wickford"} , "answeringMemberPrinted" : {"_value" : "Mr Mark Francois"} , "dateOfAnswer" : {"_value" : "2014-10-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/93136/answer/previousversion/23529", "answeringMember" : {"_about" : "http://data.parliament.uk/members/1444", "label" : {"_value" : "Biography information for Mr Mark Francois"} } , "answeringMemberConstituency" : {"_value" : "Rayleigh and Wickford"} , "answeringMemberPrinted" : {"_value" : "Mr Mark Francois"} } , "questionFirstAnswered" : [{"_value" : "2014-10-27T16:47:46.6438515Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2014-10-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Depleted Uranium"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Defence, what his policy is on the use of depleted uranium by UK armed forces operating in Iraq and Syria.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4062", "label" : {"_value" : "Biography information for Lord Goldsmith of Richmond Park"} } , "tablingMemberConstituency" : {"_value" : "Richmond Park"} , "tablingMemberPrinted" : [{"_value" : "Zac Goldsmith"} ], "uin" : "210447"} , {"_about" : "http://data.parliament.uk/resources/92008", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/92008/answer", "answerText" : {"_value" : "
Reports of suspected adverse drug reactions (ADRs) are collected by the Medicines and Healthcare products Regulatory Agency (MHRA) and Commission for Human Medicines (CHM) through the spontaneous reporting scheme, the Yellow Card Scheme.<\/p>
<\/p>
<\/strong><\/p> <\/p> The Yellow Card Scheme collects information relating to suspected adverse drug reactions, which include both serious and non-serious effects which a doctor or patient suspects may have been due to a medicine. The MHRA has received a total of 1207 suspected ADR reports in association with citalopram between 1 January 2009 and 31 August 2014. This number includes reports received directly from healthcare professionals, patients and indirectly through pharmaceutical companies which have a legal obligation to report suspected ADRs. The number of reports received directly from the NHS cannot be determined.<\/p> <\/p> <\/p> <\/p> The inclusion of a particular ADR in a report does not necessarily mean it has been caused by the drug, only that the reporter had a suspicion it may have, or it had a close temporal relationship to the administration of the suspect drug. The fact that symptoms occur after a treatment does not necessarily mean that they have been caused by the drug itself, as underlying illnesses and other conditions may be responsible.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-10-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-16T16:18:40.6444012Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-09-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antidepressants"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many incidents have been recorded by the NHS of Citalopram leading to the deterioration of a patient's health in the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4062", "label" : {"_value" : "Biography information for Lord Goldsmith of Richmond Park"}
}
, "tablingMemberConstituency" : {"_value" : "Richmond Park"}
, "tablingMemberPrinted" : [{"_value" : "Zac Goldsmith"}
], "uin" : "209345"}
, {"_about" : "http://data.parliament.uk/resources/92114", "AnsweringBody" : [{"_value" : "Department for Business, Innovation and Skills"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/92114/answer", "answerText" : {"_value" : " BIS\u2019s director with responsibility for trade and investment policy represented the UK at the Trade Policy Committee of 12 September 2014.<\/p> The Government supports the inclusion of an Investor-State Dispute Settlement clause in CETA, as part of a significantly wider trade deal which could deliver economic benefits to the UK of up to £1.3 billion. The Government believes the negotiated text strikes an appropriate balance, ensuring a level of protection that would support investment between EU and Canada while also preserving the right of EU Member State governments to regulate in the public interest.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4070", "label" : {"_value" : "Biography information for Matt Hancock"}
}
, "answeringMemberConstituency" : {"_value" : "West Suffolk"}
, "answeringMemberPrinted" : {"_value" : "Matthew Hancock"}
, "dateOfAnswer" : {"_value" : "2014-10-15", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-15T13:39:43.1941849Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "26"}
, "answeringDeptShortName" : {"_value" : "Business, Innovation and Skills"}
, "answeringDeptSortName" : {"_value" : "Business, Innovation and Skills"}
, "date" : {"_value" : "2014-09-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Comprehensive Economic and Trade Agreement"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Innovation and Skills, whether the Government's representative at the meeting of the EU Trade Policy Committee on 12 September 2014 supported the European Commission's inclusion of the Investor-State Dispute Mechanism in the Comprehensive Economic and Trade Agreement; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4062", "label" : {"_value" : "Biography information for Lord Goldsmith of Richmond Park"}
}
, "tablingMemberConstituency" : {"_value" : "Richmond Park"}
, "tablingMemberPrinted" : [{"_value" : "Zac Goldsmith"}
], "uin" : "209693"}
, {"_about" : "http://data.parliament.uk/resources/92209", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/92209/answer", "answerText" : {"_value" : " The Foreign and Commonwealth Office recently funded a project led by the Royal Society for the Protection of Birds (RSPB) to carry out the first ever stocktake of species in the UK\u2019s Overseas Territories (UKOTs). The study, completed between January 2013 and March 2014, brought together all known species records and conservation assessments. It found that there are at least 1,500 endemic species in the UKOTs and that 145 (9%) of these have had their global conservation status assessed.<\/p> <\/p> The report of the study\u2019s findings, \u2018The UK\u2019s Wildlife Overseas: A stocktake of nature in our Overseas Territories\u2019, was published on 5 June 2014 and can be found on the RSPB\u2019s website at:<\/p> <\/p>